TITLE

Medical Conditions and Their Commonly Used Drugs

PUB. DATE
January 2007
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2007, pxxii
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents a list of medical conditions and the commonly used drugs for them, including drugs for acute myocardial infarction, AIDS and HIV infection and Alzheimer's disease.
ACCESSION #
23970237

 

Related Articles

  • Coreg OK'd for expanded use.  // Drug Topics;4/7/2003, Vol. 147 Issue 7, p7 

    Reports on the U.S. Food and Drug Administration's (FDA) approval of carvedilol for use in patients who have had a myocardial infarction (MI) and who have left ventricular dysfunction. Indication for essential hypertension; Reduction of the risk of mortality.

  • Focus on donepezil. Lipson, Loren G.; Rho, Jay P.; Chow, Moses S.S. // Formulary;Jul97, Vol. 32 Issue 7, p677 

    Provides information on the drug Donepezil HCl approved by the Food and Drug Administration for the treatment of Alzheimer's disease. Chemistry and pharmacology of the drug; Pharmacokinetics; Result of the clinical trials conducted on the drugs; Adverse effects of the drug; Dosing and...

  • Drug watch: Alzheimer's disease.  // Formulary;May99, Vol. 34 Issue 5, p470 

    Lists drugs for Alzheimer's disease with their proposed formulation and status given by the Food and Drug Administration in the United States. Includes galanthamine; Lazabemide; Memantine; SB202026; Propentofylline; Rivastigmine; Olanzapine; Selegiline; Tacrine; AF-102B; Metrifonate;...

  • Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer's Disease: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. Shifu, X.; Heqin, Y.; Peifen, Y. // Clinical Drug Investigation;2000, Vol. 19 Issue 1, p43 

    Objective: This study evaluated the efficacy and tolerability of FPF 1070 (cerebrolysin) in patients with mild to moderately severe Alzheimer's disease (AD). Methods: The trial was of a multicentre, double-blind, parallel-group design. 157 patients aged 55 to 85 years were randomised to...

  • Tacrine and Alzheimer disease.  // WHO Drug Information;1999, Vol. 13 Issue 1, p7 

    Reports that the Dementia Trialists Collaboration Group has carried out a meta-analysis of tacrine in patients with Alzheimer disease. Determination of the effects of tacrine in symptoms in terms of cognitive performance, clinical global impression of change, behavior and functional autonomy;...

  • Most AD drug treatment complies with guidelines in France.  // PharmacoEconomics & Outcomes News;7/21/2012, Issue 658, p6 

    The article discusses research on the use of anti-Alzheimer's drugs in France, referencing a study by K. Tifratene and colleagues published in the June 20, 2012 issue of "Pharmacoepidemiology."

  • New Drugs for Alzheimer's Disease. Delagarza, Vincent W. // American Family Physician;10/1/1998, Vol. 58 Issue 5, p1175 

    Presents information on Alzheimer's disease, and drugs which are used in the treatment of the disease. Information on the characteristics of Alzheimer's disease; Identification on the drugs used in the treatment of the disease; Examination of the relationship between amyloid plaques,...

  • Alzheimer's Treatments Rush to a Growing Market. Jarvis, Lisa // Chemical Market Reporter;03/19/2001, Vol. 259 Issue 12, p5 

    Discusses the market growth of drugs for Alzheimer's disease (AD) in the United States (U.S.). Value of the AD drug market in 1999; Forecast on the growth rate of AD drugs by 2006; Details on the AD drugs approved in the U.S.

  • Assault on Alzheimer's. Tarlach, Gemma M. // Drug Topics;6/15/98, Vol. 142 Issue 12, p49 

    Reports that a number of pharmaceutical firms are developing drugs to treat Alzheimer's and its symptoms. Information on phase II trials of compound AIT-082 in a number of patients by NeoTherapeutics of Irvine, California; What preclinical studies indicated; Release of guidelines for agitation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics